Three innovative approaches to treating infections, fighting cancer, and enhancing the body’s immune system have been selected for funding through the Cornell Center for Immunology's 2025 Multidisciplinary Seed Grants.
The new Startup Cornell podcast episode features Van Hamilton Barbeau '11, MS/MBA '20, AVP at Ochsner Ventures, the venture capital arm of Ochsner Health.
Using machine learning technology, a new study has identified three distinct profiles describing social and economic factors that are associated with a higher risk of suicide.
A total of 450 expected graduates in the Class of 2025 received their degrees from Weill Cornell Medicine during the institution’s annual Commencement ceremony, held May 15 at Carnegie Hall.
For her work supporting the Ithaca community and people struggling with incarceration and drug addiction across New York, Netra Shetty ’25 earned the 2025 University Relations Campus Community Leadership Award.
Weill Cornell Medicine has received a projected $4 million grant to conduct a clinical trial testing whether a new imaging approach could reduce the need for biopsies to monitor prostate cancer.
Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the injectable drugs.
Weill Cornell Medicine and colleagues in Tanzania are fostering a new generation of M.D./Ph.D. researchers, with implications for improved health care outcomes worldwide.
